ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Ira Kline, NCI researcher, Dead At 69; Massey Recruits Scientists; ACR Awards

October 15, 1993

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

Acupuncture Eases Radiation-Induced Dry Mouth In Patients

April 24, 2009

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

NCCS Networker Volume 4 Issue 3, Summer 1990

June 13, 1990

Large Pregnancy Weight Gain Raises Risk For Breast Cancer

May 31, 2002